A Phase 1 Parallel Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of Formulations of a 7-Day Application Donepezil Transdermal Delivery System (TDS) in Healthy Female Volunteers

Trial Profile

A Phase 1 Parallel Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of Formulations of a 7-Day Application Donepezil Transdermal Delivery System (TDS) in Healthy Female Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Jul 2016

At a glance

  • Drugs Donepezil (Primary) ; Donepezil
  • Indications Alzheimer's disease
  • Focus Pharmacokinetics
  • Most Recent Events

    • 28 Jul 2016 Status changed from recruiting to completed.
    • 27 Jul 2016 Results published in a Corium International media release.
    • 27 Jul 2016 Results presented at the Alzheimer's Association International Conference 2016 (AAIC), according to a Corium International media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top